Xr Securities LLC Merck & Co., Inc. Transaction History

Xr Securities LLC

$342 Million
Q3 2024

A detailed history of Xr Securities LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Xr Securities LLC holds 1,789 shares of MRK stock, worth $175,411. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,789

Previous 1,864 4.02%

Holding current value

$175,411

Previous $230,000 11.74%

% of portfolio

0.06%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$111.15 - $128.97 $8,336 - $9,672	-75 Reduced 4.02%	1,789 $203,000
Q2 2024 Aug 05, 2024	BUY	$123.8 - $132.96 $230,763 - $247,837	1,864 New	1,864 $230,000
Q4 2022 Jan 03, 2023	BUY	$87.44 - $112.11 $561,539 - $719,970	6,422 New	6,422 $713,000
Q2 2022 Jul 14, 2022	SELL	$83.49 - $94.64 $424,797 - $481,528	-5,088 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$73.51 - $82.4 $10,438 - $11,700	-142 Reduced 2.72%	5,088 $417,000
Q1 2021 Apr 29, 2021	SELL	$68.86 - $81.11 $263,182 - $310,002	-3,822 Reduced 42.22%	5,230 $403,000
Q4 2020 Jan 13, 2021	BUY	$71.77 - $79.65 $140,382 - $155,795	1,956 Added 27.56%	9,052 $740,000
Q3 2020 Oct 28, 2020	SELL	$73.18 - $82.95 $33,516 - $37,991	-458 Reduced 6.06%	7,096 $589,000
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $28,379 - $32,292	-403 Reduced 5.06%	7,554 $584,000
Q1 2020 Apr 09, 2020	BUY	$63.36 - $87.82 $342,840 - $475,194	5,411 Added 212.53%	7,957 $612,000
Q4 2019 Jan 06, 2020	BUY	$77.58 - $87.54 $197,518 - $222,876	2,546 New	2,546 $232,000
Q2 2019 Jul 10, 2019	SELL	$69.84 - $81.59 $641,759 - $749,730	-9,189 Closed	0 $0
Q1 2019 Apr 08, 2019	BUY	$69.58 - $79.36 $639,370 - $729,239	9,189 New	9,189 $764,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.

Account

Xr Securities LLC Merck & Co., Inc. Transaction History